These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4188623)

  • 1. Metabolic and clinical effects of glibenclamide.
    Davidson M; Lewis AA; De Mowbray RR; Boucher BJ; Oakley NW; Nabarro JD; Ginsburg J; Beaconsfield P
    Lancet; 1970 Jan; 1(7637):57-61. PubMed ID: 4188623
    [No Abstract]   [Full Text] [Related]  

  • 2. Biguanides and the metabolic responses to exercise.
    Botha JL; Vinik AI; van Tonder S; Lund A; Waynik J; Jackson WP
    S Afr Med J; 1978 Mar; 53(9):313-8. PubMed ID: 653542
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.
    Sönksen PH; Lowy C; Perkins JR; West TE
    Diabetologia; 1981; 20(1):22-30. PubMed ID: 6781962
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of intermediary metabolism under loading with glibenclamide].
    Schräpler P; Petrides P
    Arzneimittelforschung; 1969 Oct; 19(10):1729-31. PubMed ID: 5395375
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic rhythms in normal and diabetic man. Studies in insulin-treated diabetes.
    Alberti KG; Dornhorst A; Rowe AS
    Isr J Med Sci; 1975 Jun; 11(6):571-80. PubMed ID: 1158666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].
    Appels A; Kattermann R; Proschek H; Hubrich K; Frerichs H; Söling HD; Creutzfeldt W
    Diabetologia; 1968 Aug; 4(4):210-20. PubMed ID: 4902712
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood glucose variations and clinical experience with glibenclamide in diabetes mellitus.
    O'Sullivan DJ; Cashman WF
    Br Med J; 1970 Jun; 2(5709):572-4. PubMed ID: 5526612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic intermediates in patients with diabetes mellitus--pyruvates, alpha-ketoglutarates and lactates].
    Sadanaga T; Miyao S; Mimura G
    Rinsho Byori; 1972 Jan; 20(1):10-5. PubMed ID: 5063726
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and metabolic study in diabetic patients treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlihson RW; Woodroffe F
    Br Med J; 1970 Jun; 2(5709):568-70. PubMed ID: 5526611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin-stimulating properties of Glybenclamide (HB 419) in healthy subjects. Comparative studies with tolbutamide].
    Brunetti P; Cozzolino G; Santeusanio F; Arena D; De Ciuceis P; Marri G; Migliorini E
    Acta Diabetol Lat; 1969; 6(2):283-98. PubMed ID: 5397408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral therapy of diabetes].
    Presse Med (1893); 1969 Jun; 77(31):1117-20. PubMed ID: 5793543
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH; Lowy C; Perkins JR; Lim HS
    Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of blood sugar, blood pyruvate and blood lactic acid after oral glucose loading in 30 elderly diabetics].
    DI SALVO C
    G Gerontol; 1959 Dec; 7():945-6. PubMed ID: 13816485
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
    Sitprija S; Vajanamarhutue C; Bunnag S
    J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of blood sugar, blood pyruvate and blood lactic acid after oral sulfanylurea loading in 34 diabetics].
    POLOSA P; DI SALVO C
    G Gerontol; 1959 Dec; 7():988-92. PubMed ID: 14433897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of the blood sugar, blood pyruvate and blood lactic acid after insulin loading in a group of 10 elderly diabetics].
    DI SALVO C
    G Gerontol; 1959 Dec; 7():947-8. PubMed ID: 13816486
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic effects of phenethylbiguanide in normal subjects and in diabetic patients.
    FAJANS SS; MOORHOUSE JA; DOORENBOS H; LOUIS LH; CONN JW
    Diabetes; 1960; 9():194-201. PubMed ID: 13821364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.